Dominance of Small-Molecule Drugs
SESSION 1. Dominance of Small-Molecule Drugs
Small-molecule pharmaceuticals have long been the foundation of therapeutic interventions, offering versatility and efficacy. This segment will delve into contemporary trends in the development of these drugs, highlighting innovations in drug design and targeted therapies, particularly in oncology. Additionally, it will address advancements in oral drug delivery systems, safety considerations, and global market dynamics.
Sub-Sessions:
Track 1-1 Innovations in Drug Design
Track 1-2 Targeted Therapies in Oncology
Track 1-3 Oral Drug Delivery Systems
Track 1-4 Small-Molecule Drug Safety
Track 1-5 Global Market Trends